Advances in systemic delivery of anti-cancer agents for the treatment of metastatic cancer
Introduction: The successful treatment of metastatic cancer is refractory to strategies employed to treat confined, primary lesions, such as surgical resection and radiation therapy, and thus must be addressed by systemic delivery of anti-cancer agents. Conventional systemically administered chemoth...
| Main Authors: | , , |
|---|---|
| Format: | Journal article |
| Published: |
Taylor and Francis
2016
|